Concepedia

Author

Pierre Dayer

University Hospital of Geneva

Also Known As

Dayer, P, Dayer, P., Nicole Vogt-Ferrier, P DAYER, P Dayer, P. DAYER, P. Dayer, Pierre Dayer, Pierre G. Dayer

287

Publications

11.2K

Citations

60

H-Index

153

Concepts

All Affiliations

University Hospital of GenevaUniversity of GenevaInsermGeneva CollegeInstitut Gustave Roussy
PD

About

Pierre Dayer is an author at University Hospital of Geneva specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

43

82

5.6K

2

Health Sciences

14

16

1.2K

3

Public Health

11

12

771

4

Natural Sciences

7

7

431

5

Arts

1

1

49

Pierre Dayer

×

129

Publications

9.8K

Citations

57

H-Index

YearCitations

Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism

Yvan Gasche, Youssef Daali, Marc Fathi,

New England Journal of Medicine

2004

696

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

Jules Desmeules, Christine Cedraschi, Elisabetta Rapiti,

Arthritis & Rheumatism

2003

556

The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients

J Fabré, L. P. Balant, Pierre Dayer,

Kidney International

1982

306

Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver

T. Leemann, C. Transon, Pierre Dayer

Life Sciences

1993

267

Contribution of monoaminergic modulation to the analgesic effect of tramadol

Jules Desmeules, Valérie Piguet, L Collart,

British Journal of Clinical Pharmacology

1996

238

Impact of environmental and genetic factors on codeine analgesia

Jules Desmeules, Marie-Paule Gascon, Pierre Dayer,

European Journal of Clinical Pharmacology

1991

234

Drug-Induced Long QT Syndrome in Injection Drug Users Receiving Methadone

Georg Ehret, Cathy Voide, Marianne Gex‐Fabry,

Archives of Internal Medicine

2006

226

Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)

Pierre Dayer, Jules Desmeules, T. Leemann,

Biochemical and Biophysical Research Communications

1988

208

A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin

Ronald J. Ferguson, Sonia M. F. de Morais, Simone Benhamou,

Journal of Pharmacology and Experimental Therapeutics

1998

199

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Youssef Daali, Michel Wagner, Gérard Hopfgartner,

British Journal of Pharmacology

2010

197

Page 1